General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

RightMedicineFebruary 22 2016

A toolkit for pharmacists to lobby MSPs and raise awareness of pharmacy issues with candidates in the Scottish Parliamentary election is now available.

The Royal Pharmaceutical Society in Scotland has issued the Local Advocacy Toolkit ahead of the Scottish parliamentary election on May 5.

Designed to be used in conjunction with the recently launched RPSiS manifesto, ‘Right Medicine – Better Health – Fitter Future’, the toolkit “gives members practical guidance on building relationships and influencing their MSP candidates.”

It provides tips on pharmacy visits, setting agendas, following up, local press and social media. It also provides templates for letters and press releases.”

The Society is also calling for candidates to sign the pledge on the front of the manifesto document in support of pharmacy initiatives, and to tweet the signing using the hashtag #pharmacySP16.

Susanne Cameron-Nielsen, Head of External Relations at RPSiS, said the manifesto “is based on input from our members and we need their help in supporting it – that’s why we created the Local Advocacy Toolkit.

“We want candidates to recognise the value of pharmacists to their constituents’ health and to their local communities. Everyone working in the profession has a story about their unique contribution to patient care. This toolkit is designed to help [pharmacists] reach out to candidates and share this story.”

Link:

RPSiS announcement

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...